Professor Benedikt Kessler Professor Benedikt Kessler (University of Oxford) presents his work on ubiquitin and protease biology. Hosted by Dr Adam Dowle.

Professor Benedikt Kessler

Benedikt is a Professor of Biochemistry and Mass Spectrometry at the Target Discovery Institute, University of Oxford. Kessler received a B.A. in Biochemistry from Swiss Federal Institute of Technology in 1992. He then joined Ludwig Institute for Cancer Research where he received his Ph.D. in Immunology. He completed his post-doctoral training at Harvard Medical School in the laboratory of Hidde Ploegh where he studied the role of proteolysis in antigen processing and presentation. In 2001, Kessler joined the Harvard Medical School as an Instructor in Pathology. He left Harvard in 2004 and moved to the United Kingdom, where he joined the University of Oxford as a Research Group Leader. Later he started teaching at the University of Oxford, becoming a Full Professor of Biochemistry & Life Science Mass Spectrometry in 2014. 

Kessler was part of the DUB Alliance, a group that is working to develop novel drugs against deubiquitylating enzymes (DUBs). He is currently a member of the Innovative Technology Enabling Network (ITEN), a scientific consortium that explores DUBs as cancer targets coordinated by Pfizer.